Citation: H. Krum et S. Lim, Pharmacoeconomics of beta-blockers: effective and cost-effective therapy in chronic heart failure, EUR J HE FA, 3(4), 2001, pp. 399-402
Citation: J. Martin et H. Krum, The HEART FAILURE Journal Club: a review of publications on heart failure in American Heart Journal, EUR J HE FA, 3(1), 2001, pp. 125-137
Citation: M. Nelson et al., A systematic review of predictors of maintenance of normotension after withdrawal of antihypertensive drugs, AM J HYPERT, 14(2), 2001, pp. 98-105
Authors:
Pellizzer, AM
Kamen, PW
Esler, MD
Lim, S
Krum, H
Citation: Am. Pellizzer et al., Comparative effects of mibefradil and nifedipine gastrointestinal transport system on autonomic function in patients with mild to moderate essential hypertension, J HYPERTENS, 19(2), 2001, pp. 279-285
Authors:
Krum, H
Tonkin, AM
Currie, R
Djundjek, R
Johnston, CI
Citation: H. Krum et al., Chronic heart failure in Australian general practice - The Cardiac Awareness Survey and Evaluation (CASE) Study, MED J AUST, 174(9), 2001, pp. 439-444
Authors:
Nelson, MR
McNeil, JJ
Peeters, A
Reid, CM
Krum, H
Citation: Mr. Nelson et al., PBS/RPBS cost implications of trends and guideline recommendations in the pharmacological management of hypertension in Australia, 1994-1998, MED J AUST, 174(11), 2001, pp. 565-568
Authors:
Tzanidis, A
Lim, S
Hannan, RD
See, F
Ugoni, AM
Krum, H
Citation: A. Tzanidis et al., Combined angiotensin and endothelin receptor blockade attenuates adverse cardiac remodeling post-myocardial infarction in the rat: Possible role of transforming growth factor beta(1), J MOL CEL C, 33(5), 2001, pp. 969-981
Citation: Sd. Katz et H. Krum, Acetylcholine-mediated vasodilation in the forearm circulation of patientswith heart failure: Indirect evidence for the role of endothelium-derived hyperpolarizing factor, AM J CARD, 87(9), 2001, pp. 1089-1092
Citation: H. Krum, The therapeutic role of beta-adrenoceptor-blocking agents in severe heart failure, PREVENTION OF DISEASE PROGRESSION THROUGHOUT THE CARDIOVASCULAR CONTINUUM, 2001, pp. 96-106
Citation: H. Krum, Tolerability of anti-adrenergic treatment of congestive heart failure in daily practice, PREVENTION OF DISEASE PROGRESSION THROUGHOUT THE CARDIOVASCULAR CONTINUUM, 2001, pp. 107-116
Authors:
Snell, GI
Kotsimbos, TC
Levvey, BJ
Skiba, M
Rutherford, DM
Kong, DCM
Williams, TJ
Krum, H
Citation: Gi. Snell et al., Pharmacokinetic assessment of oral ganciclovir in lung transplant recipients with cystic fibrosis, J ANTIMICRO, 45(4), 2000, pp. 511-516
Authors:
Martin, P
Tzanidis, A
Stein-Oakley, A
Krum, H
Citation: P. Martin et al., Effect of a highly selective endothelin-converting enzyme inhibitor on cardiac remodeling in rats after myocardial infarction, J CARDIO PH, 36, 2000, pp. S367-S370
Citation: Sl. Whorlow et H. Krum, Meta-analysis of effect of beta-blocker therapy on mortality in patients with New York Heart Association class IV chronic congestive heart failure, AM J CARD, 86(8), 2000, pp. 886
Authors:
Hare, DL
Ryan, TM
Selig, SE
Pellizzer, AM
Wrigley, TV
Krum, H
Citation: Dl. Hare et al., Resistance exercise training increases muscle strength, endurance, and blood flow in patients with chronic heart failure, AM J CARD, 83(12), 1999, pp. 1674